Biomarkers at the crossroads of inflammation and degeneration in Parkinson’s disease: The diagnostic potential of MCP-1 and alpha-synuclein

Key Points

• The inflammatory biomarker MCP-1 correlates significantly with degeneration in Parkinson’s disease.
• MCP-1 and alpha-synuclein levels were closely monitored to assess their diagnostic capabilities.
• Observational analysis focused on the relationship between inflammation and degeneration markers in the disease.
• Understanding these biomarkers may highlight new pathways for diagnostics and treatments.